SCINAI IMMUNOTHERAPEUTICS LTD. Increase (Decrease) in Accounts Payable, Trade
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Increase (Decrease) in Accounts Payable, Trade of $31.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2026-04-01
- SCINAI IMMUNOTHERAPEUTICS LTD. increase (decrease) in accounts payable, trade for the quarter ending 2023-06-30 was -$660.00K.
- SCINAI IMMUNOTHERAPEUTICS LTD. increase (decrease) in accounts payable, trade for the quarter ending 2023-03-31 was $629.00K, a 102.25% increase year-over-year.
- SCINAI IMMUNOTHERAPEUTICS LTD. increase (decrease) in accounts payable, trade for the quarter ending 2022-06-30 was -$628.00K.
- SCINAI IMMUNOTHERAPEUTICS LTD. increase (decrease) in accounts payable, trade for the quarter ending 2022-03-31 was $311.00K.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 12 month |
|---|---|---|---|
| 2025-12-31 | $31.00K 20-F · filed 2026-04-01 | ||
| 2025-06-30 | $283.00K 6-K · filed 2025-09-02 | ||
| 2024-12-31 | -$156.00K 20-F · filed 2026-04-01 | ||
| 2024-06-30 | $125.00K 6-K · filed 2025-09-02 | ||
| 2023-12-31 | -$150.00K 20-F · filed 2026-04-01 | ||
| 2023-06-30 | -$660.00K derived: 6-K 6 month − 10-Q 3 month · filed 2024-09-09 | -$31.00K 6-K · filed 2024-09-09 | |
| 2023-03-31 | $629.00K 10-Q · filed 2023-05-15 | ||
| 2022-12-31 | -$175.00K 20-F · filed 2025-05-07 | ||
| 2022-06-30 | -$628.00K derived: 6-K/A 6 month − 10-Q 3 month · filed 2023-08-18 | -$317.00K 6-K/A · filed 2023-08-18 | |
| 2022-03-31 | $311.00K 10-Q · filed 2023-05-15 | ||
| 2021-12-31 | $3.00K 20-F · filed 2024-05-15 |